A

ADC Therapeutics SA

D
ADCT
USD
0.13
(4.2071%)
Market Closed
11,855.00
Volume
-1.59
EPS
-
Div Yield
-1.267717
P/E
311,204,789.00
Market Cap
Today
4.2071%
1 Week
9.898%
1 Month
9.898%
6 Months
-31.049%
12 Months
308.629%
Year To Date
92.814%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
ANET
ANET
17.63
(4.8742%)
USD
F
FFIV
3.96
(1.854%)
USD
FTNT
FTNT
0.97
(1.299%)
USD
J
JNPR
-0.005
(-0.0128%)
USD
PANW
PANW
3.73
(1.131%)
USD
CSCO
CSCO
0.84
(1.6604%)
USD
C
CIEN
1.56
(2.765%)
USD
AVGO
AVGO
5.73
(3.5434%)
USD
N
NTGR
0.16
(0.7793%)
USD
MRVL
MRVL
3.34
(4.6681%)
USD

Title:
ADC Therapeutics SA

Sector:
Healthcare
Industry:
Biotechnology
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
Do you need help or have a question?
Contact Us